secwatch.observer — SEC 8-K summary
======================================

Issuer:     PetVivo Holdings, Inc. (PETV)
CIK:        0001512922
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001493152-23-040985
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetVivo Q2 FY2024 net loss widens to $3.66M; revenue down to $207K
------------------------------------------------------------------

- Revenue $207,366 vs $223,280 YoY, driven by lower clinic sales ($63,760 vs $105,016).
- Net loss $3.66M ($0.28 EPS) vs $2.11M ($0.21 EPS) YoY; operating loss $2.94M.
- Raised $2.35M from convertible note and registered direct offering in Q2.
- Entered ATM sales agreement for up to $2.5M; raised additional $870K post-quarter.
- Cash $55K at Sept 30, 2023; working capital $100K; clinical trial data for Spryng released.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512922/000149315223040985/0001493152-23-040985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512922/000149315223040985/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-040985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer